Rapid induction of malignant tumor in Sprague-Dawley rats by injection of RK3E-ras cells

Cancer Letters

Volumn 235, Issue 1, 2006, Pages 53-59

  Kim, Soo A ^a   Kim, Hyun Woo ^a   Kim, Do Kyung ^a   Kim, Su Gwan ^a   Park, Joo Cheol ^a   Kang, Dong Wan ^a   Kim, Si Wouk ^a   Ahn, Sang Gun ^a   Yoon, Jung Hoon ^a  

^a Chosun University   (South Korea)

Author keywords

k ras; RK3E; Sprague Dawley rat; Tumor model

Indexed keywords

K RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER SCREENING; CARCINOGENESIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EXPERIMENTAL MODEL; GENE INDUCTION; LUNG INFILTRATE; MALE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL; TUMOR VOLUME; VEIN;

ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENES, RAS; INJECTIONS, SUBCUTANEOUS; KIDNEY; MALE; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 33645885047     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.04.003     Document Type: Article

References (23)

1. Akla B., Monteil J., Paraf F., Sturtz F., and Rigaud M. A new orthotopic model of human breast cancer immunocompetent rats. Anticancer Res. 23 (2003) 3761-3766
2. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
3. Choy G., O'Connor S., Diehn F.E., Costouros N., Alexander H.R., Choyke P., and Libutti S.K. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques (2003) 1022-1026 see also pp. 1028-1030
4. Yoshida T., Ohnami S., and Aoki K. Development of gene therapy to target pancreatic cancer. Cancer Sci. 95 (2004) 283-289
5. Gould M.N. Rodent models for the study of etiology, prevention and treatment of breast cancer. Semin. Cancer Biol. 6 (1995) 147-152
6. Hutchinson J.N., and Muller W.J. Transgenic mouse models of human breast cancer. Oncogene 19 (2000) 6130-6137
7. Tatematsu M., Mera Y., Ito N., Satoh K., and Sato K. Relative merits of immunohistochemical demonstrations of placental. A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 6 (1985) 1621-1626
8. Haas M.J., Sattler C.A., Dragan Y.P., Gast W.L., and Pitot H.C. Multiple polypeptide hormone expression in pancreatic islet cell carcinomas derived from phosphoenolpyruvatecarboxykinase-SV40 T antigen transgenic rats. Pancreas 20 (2000) 206-214
9. Barbacid M. ras genes. Annu. Rev. Biochem. 56 (1987) 779-827
10. Sorenson G.D. Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Clin. Cancer Res. 6 (2000) 2129-2137
11. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319 (1988) 525-532
12. Losi L., Benhattar J., and Costa J. Stability of k-ras mutations throughout the natural history of human colorectal cancer. Eur. J. Cancer 28 (1992) 1115-1120
13. Dix B.R., Robbins P.D., Spagnolo D.V., Padovan G.L., House A.K., and Iacopetta B.J. Clonal analysis of colorectal tumors using k-ras and p53 gene mutations as markers. Diagn. Mol. Pathol. 4 (1995) 261-265
14. Shibata D., Schaeffer J., Li Z.H., Capella G., and Perucho M. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J. Natl Cancer Inst. 85 (1993) 1058-1063
15. Reuter C.W., Morgan M.A., and Bergmann L. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?. Blood 96 (2000) 1655-1669
16. Caulin C., Nguyen T., Longley M.A., Zhou Z., Wang X.J., and Roop D.R. Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res. 64 (2004) 5054-5058
17. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic k-ras. Genes Dev. 15 (2001) 3243-3248
18. Park C.B., Fukamachi K., Takasuka N., Han B.S., Kim C.K., Hamaguchi T., et al. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7, 12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate. Cancer Sci. 95 (2004) 205-210
19. Kolligs F.T., Hu G., Dang C.V., and Fearon E.R. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19 (1999) 5696-5706
20. Carlsson G., Gullberg B., and Hafstrom L. Estimation of liver tumor volume using different formulas-an experimental study in rats. J. Cancer Res. Clin. Oncol. 105 (1983) 20-23
21. Schmidt C.R., Gi Y.J., Coffey R.J., Beauchamp R.D., and Pearson A.S. Oncogenic Ras dominates overexpression of E-cadherin in malignant transformation of intestinal epithelial cells. Surgery 136 (2004) 303-309
22. Gilles C., Polette M., Mestdagt M., Nawrocki-Raby B., Ruggeri P., Birembaut P., and Foidart J.M. Transactivation of Vimentin by beta-catenin in human breast cancer cells. Cancer Res. 63 (2003) 2658-2664
23. Martel C., Harper F., Cereghini S., Noe V., Mareel M., and Cremisi C. Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. Cell Growth Differ. 8 (1997) 165-178